Tripeptidyl Peptidase II Mediates Levels of Nuclear Phosphorylated ERK1 and ERK2

Anne Wiemhoefer1, Anita Stargardt1, Wouter A van der Linden2

  • 1From the ‡Department of Cell Biology and Histology, Academic Medical Centre- University of Amsterdam, Meibergdreef 15, 1105AZ Amsterdam, The Netherlands;

Insights

Tripeptidyl peptidase II (TPP2) regulates crucial cell functions by controlling ERK1 and ERK2 phosphorylation. Inhibiting TPP2 impacts neuroblastoma cells and brain function, highlighting its importance in normal cellular processes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neuroscience

Background:

  • Tripeptidyl peptidase II (TPP2) is a serine peptidase implicated in diverse biological roles, including antigen processing, cell growth, DNA repair, and neuropeptide signaling.
  • The precise mechanisms by which TPP2 influences these varied cellular processes remain largely unelucidated.

Purpose of the Study:

  • To investigate the functional impact of TPP2 inhibition on cellular signaling pathways.
  • To identify proteomic changes in neuroblastoma cells following TPP2 inhibition.
  • To elucidate the role of TPP2 in neuronal function and synaptic plasticity.

Main Methods:

  • Selective inhibition of TPP2 using both a reversible inhibitor (butabindide) and a novel irreversible peptide phosphonate inhibitor.
  • Proteomic analysis of neuroblastoma cells to identify rapid changes post-inhibition.
  • Assessment of extracellular signal-regulated kinase 1 (ERK1) and ERK2 phosphorylation levels.
  • Evaluation of synaptic plasticity in hippocampal neurons following TPP2 inhibition.

Main Results:

  • TPP2 inhibition led to rapid proteomic alterations in neuroblastoma cells.
  • Inhibition of TPP2 resulted in a decrease in nuclear active, di-phosphorylated ERK1 and ERK2.
  • This reduction in ERK phosphorylation down-regulates signal transduction pathways activated by growth factors and mitogenic stimuli.
  • TPP2 inhibition in hippocampal neurons caused excessive synaptic strengthening, indicating a critical role in brain function.

Conclusions:

  • TPP2 plays a significant role in mediating cellular functions through the regulation of ERK1 and ERK2 phosphorylation.
  • TPP2 activity is essential for maintaining normal brain function, particularly synaptic regulation.
  • Targeting TPP2 may offer therapeutic avenues for conditions involving aberrant cell growth or signaling pathways.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.6K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
7.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K